Pharma left behind in US reform stakes

According to the International Herald Tribune, the pharmaceutical and biotechnology industries in the US may regret their traditional support for the Republicans as the US patent reform moves gather pace in Congress. With the Democrats now in…

Get unlimited access to all IAM content